PortfoliosLab logoPortfoliosLab logo
ISIN
US9038991025
CUSIP
903899102
IPO Date
Dec 23, 1992

Highlights

Market Cap
$102.61M
Enterprise Value
$100.59M
EPS (TTM)
-$0.49
Total Revenue (TTM)
$187.86M
Gross Profit (TTM)
$43.39M
EBITDA (TTM)
$6.73M
Year Range
$4.90 - $9.52
ROA (TTM)
-3.72%
ROE (TTM)
-6.34%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

ULBI Performance Chart

Ultralife Corporation (ULBI) is up 7.7% since the beginning of the year. At $6 per share, ULBI is trading 35.3% below its 52-week high of $10. Investors who bought $1,000 worth of ULBI shares 5 years ago would now be looking at an investment worth $717.


Loading charts...

S&P 500 Index

Returns By Period

Ultralife Corporation (ULBI) has returned 7.69% so far this year and -26.93% over the past 12 months. Over the last ten years, ULBI has returned 2.40% per year, falling short of the S&P 500 Index benchmark, which averaged 13.71% annually.


Ultralife Corporation

1D
-2.45%
1M
-4.35%
YTD
7.69%
6M
5.30%
1Y
-26.93%
3Y*
9.05%
5Y*
-6.43%
10Y*
2.40%

Benchmark (S&P 500 Index)

1D
-1.44%
1M
-1.45%
YTD
7.60%
6M
6.59%
1Y
22.24%
3Y*
19.20%
5Y*
11.54%
10Y*
13.71%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ULBI Monthly Returns History

Based on dividend-adjusted daily data since Dec 23, 1992, ULBI's average daily return is +0.08%, while the average monthly return is +1.14%. At this rate, an investment would double in approximately 5.1 years.

Historically, 47% of months were positive and 53% were negative. The best month was Jan 2000 with a return of +89.9%, while the worst month was Oct 2002 at -40.7%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 8 months.

On a daily basis, ULBI closed higher 45% of trading days. The best single day was Jul 27, 2023 with a return of +52.5%, while the worst single day was Sep 27, 2004 at -30.3%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202611.54%-11.13%14.99%5.83%5.07%-15.03%7.69%
20251.74%-17.28%-14.19%-16.73%48.88%34.63%-11.25%-12.86%-1.80%3.08%-19.06%0.53%-23.22%
20243.67%27.86%-2.54%32.80%-0.51%-8.76%12.81%-12.69%-13.58%-6.97%-8.80%-2.87%9.24%
20235.44%-0.74%-0.50%4.48%0.24%14.96%69.21%15.63%3.06%-23.98%0.94%-8.95%76.68%
2022-11.42%0.37%0.00%-8.01%-2.23%-5.80%-1.54%11.61%-3.80%2.91%-15.56%-7.66%-36.09%
2021-9.27%16.01%21.59%-4.59%15.57%-8.21%-5.25%3.15%-13.06%-12.08%-14.54%12.90%-6.65%

Benchmark Metrics

Ultralife Corporation has an annualized alpha of 11.97%, beta of 0.80, and R2 of 0.05 versus S&P 500 Index. Calculated based on daily prices since December 23, 1992.

  • This stock participated in 105.30% of S&P 500 Index downside but only 57.33% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.05 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
11.97%
Beta
0.80
0.05
Upside Capture
57.33%
Downside Capture
105.30%

Return for Risk

Risk / Return Rank

ULBI ranks 22 for risk / return — below 22% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


ULBI Risk / Return Rank: 2222
Overall Rank
ULBI Sharpe Ratio Rank: 2121
Sharpe Ratio Rank
ULBI Sortino Ratio Rank: 2323
Sortino Ratio Rank
ULBI Omega Ratio Rank: 2424
Omega Ratio Rank
ULBI Calmar Ratio Rank: 2020
Calmar Ratio Rank
ULBI Martin Ratio Rank: 2323
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Ultralife Corporation (ULBI) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ULBIBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.25

Sortino ratioReturn per unit of downside risk

-2.80

Omega ratioGain probability vs. loss probability

0.95

1.32

-0.37

Calmar ratioReturn relative to maximum drawdown

-0.60

2.46

-3.06

Martin ratioReturn relative to average drawdown

-0.96

10.92

-11.88

Dividends

Dividend History


Ultralife Corporation doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Ultralife Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Ultralife Corporation was 92.90%, occurring on Oct 18, 2002. The portfolio has not yet recovered.

The current Ultralife Corporation drawdown is 74.86%.


Related event

Drawdown

Fall

Recovery

Underwater

Dot-com crash2000–2002
-92.90%Oct 2002
7y 18d
30y 9moOct 1995 - now
1993 bear market1993
-54.43%May 1993
3mo 25d1y 3d
1y 3moJan 1993 - May 1994
1995 bear market1995
-41.74%Feb 1995
2mo 16d7mo 16d
10mo 2dNov 1994 - Sep 1995
1994 bear market1994
-20.00%Jun 1994
25d3mo 21d
4mo 16dMay 1994 - Oct 1994
1992 correction1992
-13.21%Dec 1992
6d20d
26dDec 1992 - Jan 1993

Drawdown Indicators


ULBIBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-92.90%

-56.78%

-36.12%

Max Drawdown (1Y)

Largest decline over 1 year

-44.69%

-9.10%

-35.59%

Max Drawdown (3Y)

Largest decline over 3 years

-68.83%

-18.90%

-49.93%

Max Drawdown (5Y)

Largest decline over 5 years

-68.83%

-25.43%

-43.40%

Max Drawdown (10Y)

Largest decline over 10 years

-68.83%

-33.92%

-34.91%

Current Drawdown

Current decline from peak

-74.86%

-3.21%

-71.65%

Average Drawdown

Average peak-to-trough decline

-63.49%

-10.71%

-52.78%

Ulcer Index

Depth and duration of drawdowns from previous peaks

28.03%

2.04%

+25.99%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Ultralife Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Ultralife Corporation is priced in the market compared to other companies in the Electrical Equipment & Parts industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ULBI relative to other companies in the Electrical Equipment & Parts industry. Currently, ULBI has a P/S ratio of 0.5. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ULBI in comparison with other companies in the Electrical Equipment & Parts industry. Currently, ULBI has a P/B value of 0.8. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with ULBI

Add Ultralife Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with ULBI